BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9379810)

  • 1. [Better cure for anxiety, sleep disorders, epilepsy?].
    Korpi ER; Wisden W; Lüddens H
    Lakartidningen; 1997 Sep; 94(39):3403-8. PubMed ID: 9379810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
    Möhler H
    Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New molecular targets for antianxiety interventions.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytics: past, present, and future agents.
    Nemeroff CB
    J Clin Psychiatry; 2003; 64 Suppl 3():3-6. PubMed ID: 12662127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAA receptors as targets for novel anxiolytic drugs.
    Rupprecht R; Eser D; Zwanzger P; Möller HJ
    World J Biol Psychiatry; 2006; 7(4):231-7. PubMed ID: 17071543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment.
    Smith TA
    Br J Biomed Sci; 2001; 58(2):111-21. PubMed ID: 11440203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology and clinical aspects of benzodiazepines].
    Mendlewicz J; Sevy S
    Encephale; 1985; 11(6):255-9. PubMed ID: 2869938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedative - hypnotic drugs.
    Harris E
    Am J Nurs; 1981 Jul; 81(7):1329-34. PubMed ID: 6113763
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.
    Haefely W; Facklam M; Schoch P; Martin JR; Bonetti EP; Moreau JL; Jenck F; Richards JG
    Adv Biochem Psychopharmacol; 1992; 47():379-94. PubMed ID: 1324584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benzodiazepines and benzodiazepine receptor agonists in the treatment of sleep disorders--importance and dangers. Evaluation from the clinical medical view].
    Bauer U
    Z Arztl Fortbild Qualitatssich; 2001 Jan; 95(1):17-21. PubMed ID: 11233488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology.
    Saari TI; Uusi-Oukari M; Ahonen J; Olkkola KT
    Pharmacol Rev; 2011 Mar; 63(1):243-67. PubMed ID: 21245208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of GABA in the pathophysiology and treatment of anxiety disorders.
    Nemeroff CB
    Psychopharmacol Bull; 2003; 37(4):133-46. PubMed ID: 15131523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sleep and hypnotic agents in the elderly].
    Tatarelli R; Magnani M
    Clin Ter; 1983 Mar; 104(5):417-25. PubMed ID: 6133665
    [No Abstract]   [Full Text] [Related]  

  • 14. [Benzodiazepines to people with substance abuse problems?].
    Waal H; Bramness JG
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):610-2. PubMed ID: 20349006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational use of sedative/hypnotics.
    Rogers KL
    Prim Care; 1987 Dec; 14(4):785-801. PubMed ID: 2893401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New hypnotics: perspectives from sleep physiology].
    Jufe GS
    Vertex; 2007; 18(74):294-9. PubMed ID: 18265473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines and the treatment of anxiety disorders in patients with comorbid alcohol and/or drug abuse.
    Sher L
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170-1. PubMed ID: 18354817
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacotherapy of sleep disorders using benzodiazepine hypnotics and their analogs].
    Borbély AA
    Praxis (Bern 1994); 1995 Jun; 84(24):722-5. PubMed ID: 7792469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranquilizers and sedative/hypnotics: appropriate use in the elderly.
    Allen RM
    Geriatrics; 1986 May; 41(5):75-8, 81-3, 87-8. PubMed ID: 2870007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GABAA-BZR complex as target for the development of anxiolytic drugs.
    Trincavelli ML; Da Pozzo E; Daniele S; Martini C
    Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.